BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1817186)

  • 1. Mortality among the offspring (F1) of atomic bomb survivors, 1946-85.
    Yoshimoto Y; Schull WJ; Kato H; Neel JV
    J Radiat Res; 1991 Dec; 32(4):327-51. PubMed ID: 1817186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant tumors during the first 2 decades of life in the offspring of atomic bomb survivors.
    Yoshimoto Y; Neel JV; Schull WJ; Kato H; Soda M; Eto R; Mabuchi K
    Am J Hum Genet; 1990 Jun; 46(6):1041-52. PubMed ID: 2160192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital malformations, stillbirths, and early mortality among the children of atomic bomb survivors: a reanalysis.
    Otake M; Schull WJ; Neel JV
    Radiat Res; 1990 Apr; 122(1):1-11. PubMed ID: 2320718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
    Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
    Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
    Delongchamp RR; Mabuchi K; Yoshimoto Y; Preston DL
    Radiat Res; 1997 Mar; 147(3):385-95. PubMed ID: 9052687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M; Neriishi K; Schull WJ
    Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer among children exposed to atomic bomb radiation in utero: a review.
    Kato H; Yoshimoto Y; Schull WJ
    IARC Sci Publ; 1989; (96):365-74. PubMed ID: 2680953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cancer among children exposed in utero to A-bomb radiations, 1950-84.
    Yoshimoto Y; Kato H; Schull WJ
    Lancet; 1988 Sep; 2(8612):665-9. PubMed ID: 2901525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ; Hoel DG
    Radiat Res; 1992 May; 130(2):249-66. PubMed ID: 1574582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO; Mizuno S
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.